- Home
- DRUG vs ALTI Comparison
DRUG vs ALTI Comparison
Compare DRUG & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- ALTI
- Stock Information
- Founded
- DRUG 2019
- ALTI 2020
- Country
- DRUG United States
- ALTI United States
- Employees
- DRUG N/A
- ALTI 430
- Industry
- DRUG Pharmaceuticals and Biotechnology
- ALTI Investment Managers
- Sector
- DRUG Health Care
- ALTI Finance
- Exchange
- DRUG Nasdaq
- ALTI Nasdaq
- Market Cap
- DRUG 364.8M
- ALTI 394.0M
- IPO Year
- DRUG N/A
- ALTI N/A
- Fundamental
- Price
- DRUG $56.97
- ALTI $3.89
- Analyst Decision
- DRUG Strong Buy
- ALTI
- Analyst Count
- DRUG 9
- ALTI 0
- Target Price
- DRUG $81.67
- ALTI N/A
- AVG Volume (30 Days)
- DRUG 190.6K
- ALTI 81.6K
- Earning Date
- DRUG 12-30-2025
- ALTI 11-12-2025
- Dividend Yield
- DRUG N/A
- ALTI N/A
- EPS Growth
- DRUG N/A
- ALTI N/A
- EPS
- DRUG N/A
- ALTI N/A
- Revenue
- DRUG N/A
- ALTI $226,717,000.00
- Revenue This Year
- DRUG N/A
- ALTI $19.78
- Revenue Next Year
- DRUG N/A
- ALTI $7.00
- P/E Ratio
- DRUG N/A
- ALTI N/A
- Revenue Growth
- DRUG N/A
- ALTI N/A
- 52 Week Low
- DRUG $23.18
- ALTI $2.33
- 52 Week High
- DRUG $70.23
- ALTI $4.85
- Technical
- Relative Strength Index (RSI)
- DRUG 49.89
- ALTI 50.24
- Support Level
- DRUG $55.01
- ALTI $3.85
- Resistance Level
- DRUG $61.81
- ALTI $4.33
- Average True Range (ATR)
- DRUG 3.80
- ALTI 0.19
- MACD
- DRUG -0.06
- ALTI 0.00
- Stochastic Oscillator
- DRUG 61.06
- ALTI 33.43
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.